CD8A and neoplasm: The extreme tumour mutation burden in POLEmut ECs was shown to result in a striking CD8+ lymphocytic infiltrate, as well as marked upregulation of cytotoxic T-cell effector markers in a study of 60 POLE mutant tumours.75 Another possible explanation for favourable outcomes had been that POLEmut ECs are hypersensitive to adjuvant treatment.